Amerigo Scientific Releases Optimal ZediXclusive TG6-ab ELISA (IgA) Kits to Detect TG6-Autoantibodies in Human Sera

Amerigo Scientific released ZediXclusive TG6-ab ELISA Kits (IgA), optimized based on ZediXplore TG6-ELISA Kits (IgA) to support celiac disease-related studies.

‘Zero-Copy Integration’ Innovation Framework Published as National Standard of Canada

The new standard, called Zero-Copy Integration, provides a framework enabling companies to allow access to our information, rather than make copies of it, and allows controls be tied to the data itself over how and where it can be used.

DeciBio Consulting Ranks #1 in Innovation in the Vault Consulting 50 Best Firms to Work For

DeciBio Consulting, a strategy consulting firm dedicated to accelerating the adoption and impact of precision medicine technologies, received recognition as a top consulting firm to work for in North America. DeciBio received first place in Innovation, achieving its first #1 ranking since its founding one decade ago.

Quotient Sciences Expands Formulation Development Capabilities To Further Accelerate Drug Development Timelines

Company increases laboratory capacity to meet customer demand for fully integrated drug development capabilities

ZeOmega Ranked #1 Best in KLAS for Payer Care Management Solutions

Company recognized as top performer based on Jiva Population Healthcare Enterprise Management Platform’s configurability, reliability, and functionality

Lyniate Earns Best in KLAS® Distinction for Integration Engine Category with Overall Scores of 95.7 and 92

Medical futurist names three trends shaping the future of Pharma

GCMS Analysis Technology and Application

Gas Chromatography-Mass Spectrometry (GCMS) Analysis is a powerful analytical technique used to separate, quantify and identify compounds in a sample. It is a combination of two technologies, gas chromatography and mass spectrometry.

CAS and Torx Software collaborate to streamline and accelerate small molecule discovery and design

Flagship Biosciences and Genomenon Partner to Advance Precision Medicine Development

Genomenon’s genomic landscapes enhance Flagship’s biomarker services and companion diagnostic development solutions.

BOC Sciences Live Webinar on Sensitive Nucleic Acids: Applications and Chemical Synthesis

Professor Shiyue Fang from the Department of Chemistry, Michigan Technological University, accepted BOC Sciences' invitation to present his insightful ideas about sensitive nucleic acid applications and chemical synthesis.

BOC Sciences January 2023 Promo: An Economical (Bio)chemical Source for New Year Projects

As the new year approaches, BOC Sciences' January promotion is bang on time, as usual, to thank all regular customers for the year-round support and to welcome new partners to join.

Hexarad radiology technology cuts scan allocation time by 90%

The Hexarad auto-allocation tool automatically assigns scans to the most appropriate radiologist, cutting down admin burden and leading to faster and more accurate scan results.

RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies

RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies Risk-Based Quality Management: 10 Years of enhancing Quality, Accuracy, and Integrity across all Clinical Trial Data

Creative Enzymes Introduces Two Enzyme Engineering Methods to Accelerate Related Research

Verisense Health Introduces Eminent New Board of Advisors

Verisense® Health, Inc., a digital health software and data management company, today announced the four founding members of its Board of Advisors – Dr. William Crown, Paul Hartung, Dr. Ronald C. Kessler, and Josh Tolkoff. They bring large-scale medical research, statistical, epidemiological, operational and funding expertise to the company.

Kidney and Pancreas Function Diagnostic Enzymes Are Now Available at Creative Enzymes

International Conference on Veterinary Science Medicine and Research

Worldwide veterinarian scientist and researcher are welcome to gather in our reputable conference and sharing the thoughts of experience in the field of the veterinary science medicine and research in Dubai, UAE on DEC 04-05, 2023 and Veterinary Science medicine and research webinar on DEC 11-12, 2023.

DrFirst Acquires Diagnotes Secure Messaging and Care Coordination Platform

DrFirst Acquires Diagnotes Secure Messaging and Care Coordination Platform

NCCHD in Japan Demonstrates Improved Diagnostics Rate for Rare Disease Diagnostics using OmniTier’s CompStor® Genomic Analysis Platform

Benchmark WES re-analysis study by NCCHD, Japan using OmniTier’s AI-based variant interpretation platform achieves around a 42% diagnostics rate, a 7% improvement in the average rate for diagnosing rare diseases